<code id='1E4FAA3641'></code><style id='1E4FAA3641'></style>
    • <acronym id='1E4FAA3641'></acronym>
      <center id='1E4FAA3641'><center id='1E4FAA3641'><tfoot id='1E4FAA3641'></tfoot></center><abbr id='1E4FAA3641'><dir id='1E4FAA3641'><tfoot id='1E4FAA3641'></tfoot><noframes id='1E4FAA3641'>

    • <optgroup id='1E4FAA3641'><strike id='1E4FAA3641'><sup id='1E4FAA3641'></sup></strike><code id='1E4FAA3641'></code></optgroup>
        1. <b id='1E4FAA3641'><label id='1E4FAA3641'><select id='1E4FAA3641'><dt id='1E4FAA3641'><span id='1E4FAA3641'></span></dt></select></label></b><u id='1E4FAA3641'></u>
          <i id='1E4FAA3641'><strike id='1E4FAA3641'><tt id='1E4FAA3641'><pre id='1E4FAA3641'></pre></tt></strike></i>

          knowledge

          knowledge

          author:leisure time    Page View:93
          Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT
          Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

          WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

          The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

          advertisement

          The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          What does generative AI mean for health care? We asked experts
          What does generative AI mean for health care? We asked experts

          MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

          read more
          FDA approves Recor Medical high blood pressure device
          FDA approves Recor Medical high blood pressure device

          ReCorMedical,astartupownedbyJapanesecompanyOtsukaMedicalDevices,andMedtronichaverunstudiesthatshowed

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          FDA approves Moderna’s RSV vaccine, its second licensed product

          TheFDAhasapprovedModerna’sRSVvaccineforolderadults.ModernaTheFoodandDrugAdministrationonFridayapprov